85. Idiopathic interstitial pneumonia Clinical trials / Disease details

Clinical trials : 598 / Drugs : 435 - (DrugBank : 116) / Drug target genes : 100 - Drug target pathways : 210

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05052229 (ClinicalTrials.gov)	October 1, 2021	2/9/2021	Inhaled Nitric Oxide (iNO) in Idiopathic Pulmonary Fibrosis (IPF).	Pulmonary Gas Exchange and Neuro-sensory Abnormalities in Patients With Idiopathic Pulmonary Fibrosis and Mild Mechanical Restriction. Implications for Dyspnea and Exercise Intolerance	Idiopathic Pulmonary Fibrosis	Drug: Nitric Oxide;Drug: Medical air	Queen's University	Boehringer Ingelheim	Not yet recruiting	40 Years	N/A	All	40	Early Phase 1	Canada
2	NCT03688334 (ClinicalTrials.gov)	June 1, 2018	20/9/2018	Acute Effects of Oxygen Supplementation Among IPF Patients	Acute Effects of Oxygen Supplementation During Exercise Among Patients With Idiopathic Pulmonary Fibrosis Without Resting Hypoxemia	Idiopathic Pulmonary Fibrosis	Drug: Oxygen 40 %;Drug: Medical air (sham O2)	George Papanicolaou Hospital	NULL	Unknown status	18 Years	80 Years	All	15	N/A	Greece
3	NCT03050255 (ClinicalTrials.gov)	November 2016	25/11/2016	Short-term Effects of Supplemental Oxygen in Patients With IPF	Short-term Effects of Supplemental Oxygen During Walking in Hypoxemic Patients With Idiopathic Pulmonary Fibrosis	Idiopathic Pulmonary Fibrosis (IPF)	Other: Medical air;Other: Oxygen (2Liter/min);Other: Oxygen (4Liter/min)	Schön Klinik Berchtesgadener Land	Linde AG	Completed	N/A	N/A	All	53	N/A	Germany